DOCSLIB.ORG

Essilor Logo

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Essilor Logo OUR JOURNEY TO IMPROVE VISION HAS EVOLVED OVER THE PAST 50 YEARS From BIFOCAL to PROGRESSIVE lenses for clear vision at all distances. From GLASS to PLASTIC to POLYCARBONATE lens materials for improved safety. From THICK to ULTRA-THIN lenses for better aesthetics and increased comfort. From CLEAR to PHOTOCHROMIC lenses for increased comfort in all light conditions. From front-side only UV protection to additional backside UV protection for healthier vision. We Hope You Will JOIN US On Our Next Step to Provide Eye Protection Against UV and Harmful Blue Light For All Wearers EXPOSURE TO HARMFUL BLUE LIGHT INCREASES EVERY YEAR With improved health, we are living longer but as we age, our eyes weaken and become more at risk for developing eye diseases like cataract and age-related macular degeneration (AMD).1 AVERAGE AGE OF OCCURRENCE: 2 3 4 Age-Related Macular Degeneration Sources: 1. VisionWatch, Digital Eye Strain Report Surveys – 2012 and 2014. Smick, K, O.D. (October 2014) Blue Light Basics. Optometric Management: 28-29 2. Presbyopia: http://www.pointsdevue.com/article/early-signs-and-symptoms-presbyopia 3. Cataract: http://www.pointsdevue.com/article/ageing-and-crystalline-lens, 4. AMD: http://www.pointsdevue.com/article/amd-clinical-protocol-prevention-and-outlook OUR EVOLVING LIFESTYLES MEAN THAT OUR EYES ARE CONSTANTLY EXPOSED TO HARMFUL LIGHT Sources: 1. Smick, K, O.D. (October 2014) Blue-Violet light Basics. Optometric Management: 28-29. 2. Frost & Sullivan’s Energy & Environment Outlook 2015. 2015 To-the-Point Trend 7 LED Lighting Presentation. Retrieved from http://www.slideshare.net/FrostandSullivan/2015-to-thepoint-trend-7-led-lighting 3. The Vision Council, «2015 Digital Eye Strain Report . » Hindsight is 20/20/20: Protect Your Eyes from Digital Devices UNDERSTANDING THE LIGHT SPECTRUM OUTDOORS Harmful Blue Light is 500X more intense than indoors The sun emits Harmful Blue Light all year long, and in all weather conditions The sun is the largest singular source of Harmful Blue Light The sun scatters light through the atmosphere and is up to 500x more intense than the Harmful Blue Light we are exposed to indoors INDOORS Harmful Blue Light is everywhere Blue Light is emitted by many indoor sources of light such as LED lamps and compact fluorescent light bulbs (CFLs) Harmful Blue Light is also present in modern digital devices like computer screens, tablets, and many smart phones. As the U.S. moves toward more energy-efficient light sources (LEDs), Blue Light surrounds us even more INDOOR HARMFUL BLUE LIGHT HARMFUL BLUE LIGHT has been linked to retinal disorders such as age-related macular degeneration (AMD)*, which is a leading cause of vision loss in adults over the age of 50.** Source: *Arnault E. Barrau C, Nanteau C. Gondouin P, Bigot K, et al. “Phototoxic Action Spectrum on a Retinal Pigment Epithelium Model of Age-Related Macular Degeneration Exposed to Sunlight Normalized Conditions.” PLoS ONE 8(*); e71398.doi:10.1371398.August 23,2013. **National Institues of Health National Eye Institute. Facts about Age-Related Macular Degeneration. Retrieved from: https://nei.nih.gov/health/maculardegen/armd_facts WITH AN AGING POPULATION, THE OCCURRENCE OF AMD WILL BE DOUBLED IN 30 YEARS AMD POPULATION* Worldwide est. 100 Million *Source: Simplified Extrapolation AMD model. Essilor International, DMS, EL, Jan. 2013. United nation: World Population Prospects, epidemiological and marketing studies. HARMFUL BLUE LIGHT has been linked to Retinal cell death and AMD Help us to provide patients with the Harmful Blue Light protection they need. EVERY EYE. EVERYONE. Smart Blue Filter™ Video PlayPLAY video VIDEO IN THE PAST THERE WERE TWO WAYS OF BLOCKING HARMFUL BLUE LIGHT TINT These protective methods often led patients to choose their protection based on appearance alone. Now they can choose lenses based on the protection they need! Smart Blue Filter™ Embedded protection against Harmful Blue Light in a clear lens. Absorbs Harmful Clear in color Blue Light by and appearance having protection that is embedded into the lens Transmits essential Reduces at least 20% Blue-Turquoise Light of Harmful Blue Light (in the range between (in the range between 465-495nm) No additional cost 415-455nm). THE #1 PROGRESSIVE LENS BRAND will now provide Harmful Blue Light protection at NO ADDITIONAL COST TO YOU Driving innovation in the progressive lens category! Essilor’s new, enhanced single vision solution that is backed by consumer advertising Eyezen™+ lenses alleviate digital eyestrain and reduce Harmful Blue Light All Eyezen™+ lens products will include the Smart Blue Filter™ feature Eyezen™+ lenses are an upgrade to standard single vision lenses Driving innovation in the single vision lens category! All Transitions® Lenses help protect eyes from Harmful Blue Light, both indoors and outdoors Driving innovation in the adaptive lens category! COMBINE WITH CRIZAL® FOR THE MOST COMPREHENSIVE EYE PROTECTION Eye Protect™ System Indoor Protection Smart Blue Filter Products No-Glare Lens Treatment Harmful Blue Light Protection UV Protection Varilux® Digital* Crizal Easy UV Blocks at least Crizal Alize UV Eyezen™+ HARMFUL 20% Crizal Avance UV Blue Light Transitions® Signature™ VII ESSENTIAL Crizal Sapphire UV Varilux® Digital* Blocks at least Crizal Prevencia HARMFUL Eyezen™+ 30% Blue Light ADVANCED Transitions Signature VII Transitions® XTRActive® Crizal Prevencia Blocks at least HARMFUL 45% Transitions Vantage Blue Light ULTIMATE * All Varilux Digital lenses except Varilux Physio Enhanced & Varilux Comfort Enhanced **E-SPF® is a global index rating the overall UV protection of a lens. E-SPF was developed by Essilor International and endorsed by 3rd party experts. A lens rating of E-SPF 25 means that an eye protected by the lens will receive 25 times less UV exposure than without any lens. E-SPF of 25 when Crizal is made with any lens material other than clear 1.5 plastic. Eye Protect™ System Outdoor Protection Smart Blue Filter Products No-Glare Lens Treatment Harmful Blue Light Protection UV Protection Transitions® Signature™ VII Crizal Easy UV Blocks over Crizal Alize UV HARMFUL Transitions® Vantage Blue Light 85% Crizal Avance UV Blocks over Ultimate Crizal Sapphire UV (Activated) Transitions® XTRActive HARMFUL Crizal Prevencia Blue Light 88% Blocks up to Xperio UV™ Polarized Sun Lenses HARMFUL Blue Light 92% Polarized OUTDOOR OUTDOOR * All Varilux Digital lenses except Varilux Physio Enhanced & Varilux Comfort Enhanced **E-SPF® is a global index rating the overall UV protection of a lens. E-SPF was developed by Essilor International and endorsed by 3rd party experts. A lens rating of E-SPF 25 means that an eye protected by the lens will receive 25 times less UV exposure than without any lens. E-SPF of 25 when Crizal is made with any lens material other than clear 1.5 plastic. + Smart Combination ™ ® ® Smart Blue Filter + Crizal Prevencia Smart Blue Filter™ Embedded Protection Crizal® Prevencia® No-Glare Lens Treatment Together they reduce Harmful Blue Light by 30% Allow essential UV Light Blue-Turquoise Light Harmful Blue Light *E-SPF® is a global index rating the overall UV protection of a lens. E-SPF was developed by Essilor International and endorsed by 3rd party experts. A lens rating of E-SPF 25 means that an eye protected by the lens will receive 25 times less UV exposure than without any lens. E-SPF of 25 when Crizal is made with any lens material other than clear 1.5 plastic. Summary Harmful Blue Light 3 Offer Blue Light protection 1 to everyone Harmful Blue Light has been linked The Smart Blue Filter™ feature will to retinal disorders such as age- be automatically embedded related macular degeneration within Varilux® Digital, (AMD)* which is the leading cause Transitions®, and Eyezen™+ of vision loss in adults over the age lenses. This will reduce exposure of 50.** for millions of patients in the first year alone! 2 No price increase! Valuable innovation you can pass onto your patients Differentiation through superior eye care & brands Source: *Arnault E. Barrau C, Nanteau C. Gondouin P, Bigot K, et al. “Phototoxic Action Spectrum on a Retinal Pigment Epithelium Model of Age-Related Macular Degeneration Exposed to Sunlight Normalized Conditions.” PLoS ONE 8(*); e71398.doi:10.1371398.August 23,2013. **National Institues of Health National Eye Institute. Facts about Age-Related Macular Degeneration. Retrieved from: https://nei.nih.gov/health/maculardegen/armd_facts .
Load more

Recommended publications
  • See Change Report 2018
    SEE CHANGE ERADICATING POOR VISION BY 2050 A 2018 UPDATE HUBERT SAGNIÈRES CHAIRMAN AND CHIEF EXECUTIVE OFFICER For 170 years Essilor has been on a mission to improve lives by improving sight. Every day, Essilor Group employees work to better correct and protect the vision of everyone on the planet. While 2 billion people enjoy vision correction, 2.5 billion people, 1 in 3, live with uncorrected poor vision. Today, uncorrected poor vision remains the world’s most widespread unaddressed disability, one that crosses cultural, geographic and economic lines. This is why, in line with Essilor’s mission to improve lives by improving sight, we’re working to eradicate poor vision from the world by 2050. WE’RE WORKING TO ERADICATE POOR VISION FROM THE WORLD BY 2050" VISION MATTERS 2.5 BILLION people suffer from uncorrected poor vision, meaning 1 in 3 people cannot see the world clearly.1 90% of them live in the developing world at the base of the pyramid where awareness and access to vision care is limited.2 $272 BILLION the cost to the global economy of lost productivity every year because adults with uncorrected poor vision struggle with work .3 But this doesn’t need to be the case. 80% of all vision impairments can be prevented or cured with solutions that exist today.2 SOURCES 1 Boston Consulting Group analysis of data from United Nations Development Program, Worldbank, CIA World Factbook, World Resource Institute. 2 World Health Organization. Visual impairment and blindness. Fact sheet No 282, updated 2014.World Health Organization $5 3 Smith et al: Potential lost productivity resulting from the global burden of uncorrected refractive average cost error - Bulletin of World Health Organization 2009, 87:431-437 (adjusted to 2015 population data).
    [Show full text]
  • 2018 – Sustainability Report (1
    Social, environmental and societal information 2018 Non-financial statement of Essilor International (SAS), a subsidiary of the EssilorLuxottica Group 4.2 2018 Non-financial statement of Essilor International (SAS), a subsidiary of the EssilorLuxottica Group Since October 1, 2018, Essilor International (SAS) has been It is a subpart of the EssilorLuxottica Non-financial Statement part of the EssilorLuxottica Group. found in Chapter 4 of EssilorLuxottica’s 2018 Registration This document is the Essilor International (SAS) Non-Financial Document. Statement for 2018 in which the sustainable development As regards wording, the names “Essilor” and “the Group” program and all related social, environmental and societal refer to Essilor International (SAS). CSR is the acronym for information is presented. Corporate Social Responsibility. 4.2.1 Essilor’s approach to Sustainable Development 4.2.1.1 The Essilor value chain professional customers, prescription laboratories are crucial and stakeholders for ensuring product quality and conformity. The environmental footprint of the prescription laboratories is fragmented and Essilor’s approach to sustainable development is based on limited, and derives primarily from the use of chemical products consideration of the environmental, social and societal impacts and the consumption of energy and water; of its business activities on the various stakeholders along the value chain. • optical retailers and chains: the Group supplies optical retailers and chains in over 100 countries and sells optical products online (contact lenses, prescription spectacles and sunglasses) Value chain through several local websites, serving a rapidly expanding Throughout the Essilor value chain, from product design to global distribution channel. Information security, data marketing, the Group’s business activities impact on the protection and product promotion have been identified as environment and on society at large.
    [Show full text]
  • Legal Rankings 2017 2017
    GLOBAL M&A MARKET REVIEW LEGAL RANKINGS 2017 2017 GLOBAL M&A LEGAL ADVISORY RANKINGS The Bloomberg M&A Advisory League Tables are the definitive publication of M&A advisory rankings. The CONTENTS tables represent the top financial and legal advisors across a broad array of deal types, regions, and industry sectors. The rankings data is comprised of mergers, acquisitions, divestitures, spin-offs, debt-for-equity- 1. Introduction swaps, joint ventures, private placements of common equity and convertible securities, and the cash 2. Global M&A Heat Map injection component of recapitalization according to Bloomberg standards. 3. Global M&A Regional Review Bloomberg M&A delivers real-time coverage of the M&A market from nine countries around the world. We 4. Global M&A League Tables provide a global perspective and local insight into unique deal structures in various markets through a 6. Americas M&A Regional Review network of over 800 financial and legal advisory firms, ensuring an accurate reflection of key market trends. 7. Americas M&A League Tables Our quarterly league table rankings are a leading benchmark for legal and financial advisory performance, 9. EMEA M&A Regional Review and our Bloomberg Brief newsletter provides summary highlights of weekly M&A activity and top deal trends. 10. EMEA M&A League Tables 14. APAC M&A Regional Review Visit {NI LEAG CRL <GO>} to download copies of the final release and a full range of market specific league 15. APAC M&A League Tables table results. On the web, visit: http://www.bloomberg.com/professional/solutions/investment-banking/.
    [Show full text]
  • Essilor Labs of America Partnership
    ENVOLVE VISION – LABORATORY ORDERING FREQUENTLY ASKED QUESTIONS Q1: Does Envolve Vision offer an Open Lab Network? A1: Yes. Envolve Vision allows you unrestricted variety when it comes to laboratory and product choice. This model allows you the freedom to conduct your business as you see fit and will allow you increased revenue to the ability to recommend premium products. Q2: Is Essilor Laboratories of America (Essilor Labs) Envolve Vision’s Preferred Lab Partner? A2: Yes. Essilor Labs is the preferred lab partner for Envolve. Essilor Labis the largest and most trusted optical lab network in the United States. With more than 128 optical laboratories across the nation, they are committed to supporting Eye Care Professionals in ways that exceed expectations for service, performance, and quality. They are a full-service provider bringing extensive lens offerings, superior manufacturing, quality, and technologically advanced processing. Through Essilor Labs, you gain access to premium brands like Varilux®, Crizal®, Eyezen+™, Transitions®, and Xperio UV™. Beyond your Envolve Vision work, Essilor Labs offers services including accredited online and in-office staff training, business consulting, pricing analysis, and programs designed to build practice profitability. Q3: Which Essilor Labs can I order my Envolve Vision Jobs? A3: As an Envolve Vision provider, you may place orders at any lab within the Essilor Lab network. However, there is a list of preferred Essilor Labs*, which will offer you the lowest contracted price list when you provide a frame from your office and order lenses from the lab. Classic Optical is the exclusive supplier of the Envolve Vision frame and lens package.
    [Show full text]
  • Delivering Life-Changing Vision Care Where It Is Needed Most Contents
    DELIVERING LIFE-CHANGING VISION CARE WHERE IT IS NEEDED MOST CONTENTS HUBERT SAGNIÈRES CHAIRMAN AND CHIEF EXECUTIVE OFFICER We have welcomed the aspirational ESSILOR IS A COMPANY DRIVEN BY goals set out in the UN’s 2030 Agenda 80%* ONE CLEAR AMBITION. TO CORRECT GOOD for Sustainable Development. Society’s OF VISUAL PROBLEMS CAN AND PROTECT THE VISION OF THE challenges ahead are increasingly BE PREVENTED OR TREATED 7.4 BILLION PEOPLE WHO SHARE interconnected, requiring business, OUR PLANET. governments and civil society to work It’s been our core mission for nearly hand-in-hand. $272bn† 170 years to provide quality vision care With our many partners, we are solutions that improve lives by convinced that addressing the global A YEAR IN LOST PRODUCTIVITY DUE TO UNCORRECTED VISION improving sight. It’s that same mission issue of vision can help advance that has enabled Essilor to multiple Sustainable Development continuously create value, and to Goals. That’s because good vision is a become the undisputed world leader vital enabler, a foundation for healthy in ophthalmic optics, serving lives. Our work in the field has indeed professional customers and shown us how improving sight not only consumers in over 100 countries. improves lives, but contributes to many Every one of us should have the areas in the UN’s global agenda for opportunity to enjoy healthy vision development. throughout our lives. But poor vision In 2016 we mapped our impacts both EVERY ONE OF US SHOULD is still the world’s most widespread against our own priorities, as defined HAVE THE OPPORTUNITY TO disability.
    [Show full text]
  • 2021 Interim Financial Report 2021 Interim Financial Report Essilorluxottica
    2021 Interim Financial Report 2021 Interim Financial Report EssilorLuxottica Table of contents - First-Half 2021 Results Press Release - First-Half 2021 Management Report - First-Half 2021 Condensed Consolidated Interim Financial Statements - Statutory Auditors’ Review Report on the Interim Financial Information - Statement by the Person Responsible for the 2021 Interim Financial Report This is a free translation into English of the 2021 Interim Financial Report issued in French EssilorLuxottica’s second quarter and first half 2021 results Revenue acceleration, margin expansion and record cash flow Outlook 2021 improved Second quarter: • Revenue +9.2% versus 2019 at constant exchange rates1 • North America best performing region, EMEA and Latin America positive • Professional Solutions and Direct to Consumer both growing and accelerating • Optical and sun both growing, with sun catching up in pace • E-commerce +66% versus 2019 at constant exchange rates1, reaching 9% of total revenue First half: • Operating profit +35% versus 2019 at constant exchange rates1 • Adjusted2 operating profit margin at 18.5%, up 130 basis points versus 2019 • Free cash flow4 record generation at Euro 1.2 billion Charenton-le-Pont, France (30 July 2021, 7:00 am) – The Board of Directors of EssilorLuxottica met on 29 July 2021 to approve the condensed consolidated interim financial statements for the six months ended 30 June 2021. The Statutory Auditors have performed a limited review of these financial statements. Their report is in the process of being issued. “We delivered another strong set of results in the first half, despite the ongoing challenges of the pandemic. Our continued focus on premium products and brands, a powerful supply chain and a global community of talented and engaged employees helped us get there.
    [Show full text]
  • Reference Document 2004 2004
    REFERENCE DOCUMENT 2004 2004 2004 REFERENCE DOCUMENT ESSILOR INTERNATIONAL Compagnie Générale d’Optique ESSILOR 147, rue de Paris 94220 Charenton-le-Pont France Phone: +33 (0) 1 49 77 42 24 - Fax: +33 (0) 1 49 77 44 20 www.essilor.com A French corporation with fully paid-up capital of €36,158,669.05 Registred under the number 712 049 618 in Créteil, France. Checklist of Information Provided in Compliance with Autorité des Marchés Financiers Regulations STATEMENTS BY THE PERSONS RESPONSIBLE FOR THE ASSETS, FINANCIAL POSITION AND RESULTS REFERENCE DOCUMENT AND THE AUDIT OF THE ACCOUNTS • Consolidated financial statements and notes........... 44 to 77 • Statement by the persons responsible • Off-balance sheet commitments.............................. 67 to 71 for the Reference Document ........................................... 125 • Fees paid to the Auditors • Statement by the Auditors................................................ 126 and members of their networks ...................................... 108 • Information policy............................................................... 6 • Pro forma financial information ..................................... N/A • Regulatory ratios (banks, insurance companies, brokers. N/A GENERAL INFORMATION • Parent company financial statements and notes .... 82 to 105 • Interim consolidated financial statements....................... N/A Issuer • Applicable regulations (foreign companies)..................... N/A CORPORATE GOVERNANCE • Board of Directors...............................................
    [Show full text]
  • Présentation Powerpoint
    US Field Trip Dallas - September 28, 2016 INTRODUCTION HUBERT SAGNIÈRES US Field Trip - September 2016 2 A Strong Mission is At the Heart of our Strategy Improving Lives by Improving Sight 7.2 billion people worldwide 63% in need of vision correction 100% in need of vision protection Source: Essilor – 2015 estimates US Field Trip - September 2016 3 A Powerful Strategy to Capture All Growth Opportunities PRESCRIPTION SUNGLASSES LENSES & READERS FAST-GROWING MARKETS 10-12% €12.7bn €10bn 3-4% 6-7% ONLINE €5.8bn 14% €5.8bn ~ €28.5bn 6-7% Innovation Consumer Focus and Branding Partnerships and Acquisitions Business Interconnections Size and growth of industry segments by 2018 / Prescription sun lenses are included in prescription lenses Fast-Growing Markets include China, India, ASEAN, South Korea, Hong Kong, Taiwan, Africa, the Middle East, Russia and Latin America US Field Trip - September 2016 4 On our Way to Reach our 2018 Ambition Growth-Enhancing Innovation > €200m p.a. Branding > €200m p.a. Acquisitions Breakdown of R&D expenses Breakdown of Essilor consumer in the optical industry marketing expenses Prescription Lenses Other Sun ~30 Industry c.25% Prescription Sunwear Players ~50 Online Essilor Online ~120 c.75% Fast-Growing Markets Source: Essilor New Models US Field Trip - September 2016 5 A Unique Combination Driving for Success A powerful mission Poor vision is the world’s A clear strategy largest disability Strong teams Innovation & partnerships Entrepreneurial & global Employees aligned with shareholders through employee
    [Show full text]
  • New Results on Essilor Stellest Lens to Be Presented at the Annual Meeting
    New results on Essilor Stellest™ lens to be presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO 2021) Pivotal two-year clinical trial results demonstrate that Essilor Stellest™ lens slows down myopia progression by 67%1 These results focusing on Essilor Stellest™ lens will be presented for the first time internationally at the occasion of the 2021 Annual Meeting of the ARVO (Charenton-le-Pont, 9 April, 2021) – Essilor will unveil the pivotal two-year clinical trial results of its Stellest™ lens - its latest breakthrough spectacle lens solution in the fight against myopia. The much-anticipated two-year results demonstrate that Essilor Stellest™ lenses slow down myopia progression by 67% on average, when compared to single vision lenses, when worn at least 12 hours a day1. The presentation of this research entitled “Myopia control with spectacle lenses with aspherical lenslets: a 2-year randomized clinical trial”, will be delivered at the occasion of the Annual Meeting of the ARVO, on May 6th, 2021, by BAO Jinhua2, Associate Professor at Wenzhou Medical University, China. In 2018, Essilor’s research and development team initiated a three-year state-of-the-art clinical trial on 167 myopic children3 in its joint Research and Development Center shared with key partner, the Wenzhou Medical University, in China. This research illustrates Essilor’s commitment to fight poor vision and to find concrete solutions to slow down myopia progression in childhood. The results of this study demonstrate compelling evidence that Essilor Stellest™ lenses are one of the most effective options available for slowing down myopia progression in children today.
    [Show full text]
  • Essilor Pursues Its Partnership Strategy by Signing Nine New Transactions
    Acquisitions Essilor pursues its partnership strategy by signing nine new transactions Expanded footprint in Brazil, the United States and Europe 19 acquisitions in 2015, representing revenue of around €214 million Charenton-le-Pont, France (January 8, 2016 – 7:30 am) – Actively pursuing its growth strategy, Essilor International has announced the signing of nine additional external growth transactions representing combined annual revenue of around €60 million. These acquisitions are in line with the Company’s strategy of balanced growth that is evenly spread across developed and fast-growing markets, with the aim of strengthening Essilor’s presence in the prescription lens industry and stepping up growth momentum in the online and sunglasses segments. In developed markets, the Company completed three transactions that strengthen its ties with eyecare professionals and advance its multi-network strategy. In the United States, Essilor purchased a majority stake in The Professional Eyecare Resource Co- Operative/Infinity Vision Alliance (PERC/IVA), a group purchasing organization comprising more than 2,400 independent eye care practices. Essilor also finalized the acquisition of Vision Source, the leading service network providing services to independent optometrists, which was originally announced in July 2015. In Spain, the Company acquired a majority stake in ECP, the distribution platform of CECOP, a group purchasing organization comprising around 800 domestic optical stores as well as operations in Italy, Portugal and the United Kingdom. ECP posted revenue of almost €3 million in 2015. It will develop the Kodak® brand in Spain and Portugal, expanding the Company's local offering and conquering fresh customer segments. In Poland, Essilor enhanced its mid-range ophthalmic lens offering with the purchase of Jai Kudo Polska.
    [Show full text]
  • 2008 Interim Financial Report Essilor International
    2008 INTERIM FINANCIAL REPORT ESSILOR INTERNATIONAL Contents 1st Half 2008 Management Report p. 2 1st Half 2008 Condensed Consolidated Financial Statements p. 7 Statement by the Person Responsible for the 2008 Interim Financial Report p. 27 Statutory Auditor’s Review Report on the First Half-Year Financial Information for 2008 p. 28 This is a free translation into English of the 2008 Interim Financial Report issued in French. 1 Management Report First-Half 2008 € millions First-half 2008 First-half 2007 % change Revenue 1,520.2 1,476.9 +2.9% Contribution from operations (1) 276.3 267.3 +3.4% % of revenue 18.2% 18.1% Operating profit 261.7 253.2 +3.4% Profit attributable to equity holders 198.3 181.9 +9.0% of Essilor International % of revenue 13.0% 12.3% Basic earnings per share (in €) 0.96 0.88(2) +8.1% (1) Operating profit before share-based payments, restructuring costs and other non-recurring items, and goodwill impairment. (2) Adjusted for the two-for-one stock split on July 16, 2007. Revenue up 2.9% to €1,520.2 million Essilor’s consolidated revenue for the six months ended June 30, 2008 rose by 5.4% like-for-like and 9.6% excluding the currency effect. Changes in the scope of consolidation boosted revenue by 4.2%, reflecting the contributions of the businesses acquired in 2007 and in the first half of 2008. The currency effect was a negative 6.6%, which reduced reported growth to 2.9%. Organic growth in revenue was led by: • Very strong demand in North America, South America and most countries in Asia.
    [Show full text]
  • Essilor Case Study
    ESSILOR CASE STUDY This integrated campaign resulted in an overall response rate of 31.5%. There were 2,576 unique visits to the site which translated into an 88% conversion rate. CL IE N T: Essilor INDUSTRY: Pharmaceutical PROJEC T: Integrated Sweepstakes Campaign SG SERVICES: Direct Mail, Online Sweepstakes and Email Follow-Up BACKGROUND Essilor is the world’s leading provider of eyeglass lenses, and for over 40 years, Essilor has been dedicated to the research and innovation of comfortable and durable corrective lens design. Their Varilux lense product is designed for people over 40 who experience presbyopia, a near vision condition. PROJECT GOALS > Get the attention of hard-to-reach prescribers > Highlight the features of the Varilux brand > Keep the product top-of-mind with prescribers > Attract new prescribers > Strengthen brand loyalty > Communicate the launch in a memorable way CHALLENGES Essilor Edge’s loyalty program had to provide members with an incentive to review their launch information. They also needed to reach non-active members in a way that created awareness of the loyalty program. OUR APPROACH We developed an integrated campaign that included a high-impact Rolling cube mailer to drive members online. We also created a Sweepstakes to engage and interact with the program’s membership. SUCCESS Essilor received 1,748 total entries (23.6%) to the sweepstakes in response to the Rolling Cube mailing. Of those, there were 701 unique participants (9.5%). Overall, the integrated campaign resulted in a response rate of 31.5%. With 2,576 unique visits to the sweepstakes site, the campaign delivered a conversion rate of 88%.
    [Show full text]